Finding the Right Cell: Using Automation to Select Effective Biologic Therapies

Terry Stanton

The third annual AAOS Biologics Symposium, titled “The Next Generation of Biologics,” featured four sessions on regulatory clarity, autologous tissue processing, personalized blood products, and future biologics trends.

An Explanation of the Categorization of Osteobiologics

John Cherf, MD, MPH, MBA, FAAOS

The ISASS classified alternatives to iliac crest bone graft into six major categories: cellular-based allografts, nonstructural allografts, autologous cellular grafts, synthetic bone grafts, demineralized bone grafts (or demineralized bone matrices), and Class III drug-device combination products.